REG - Kanabo Group PLC - Result of AGM

KanaboAnnouncement

27/06/2024 17:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240627:nRSa2261Ua&default-theme=true

RNS Number : 2261U  Kanabo Group PLC  27 June 2024

27 June 2024

Kanabo Group Plc

("Kanabo" or the "Company")

 

Result of AGM

 

Kanabo Group Plc (LSE:KNB), a leading health tech company, announces that at
the Annual General Meeting ("AGM") held earlier today, eight resolutions were
duly passed. The numbers of votes for each resolution are presented below:

 

 Resolution (No. as noted on proxy form)  Total For (i)          Total Against          Withheld (ii)
                                          No. of votes  % of     No. of votes  % of     No. of votes

                                                        vote                   vote
 Resolution 1                             226,464,519   99.86%   313,881       0.14%    129,393

 Resolution 2                             218,146,960   96.31%   8,339,516     3.68%    420,817

 Resolution 3                             226,331,517   99.83%   376,111       0.17%    200,165

 Resolution 4                             218,268,057   96.28%   8,436,008     3.72%    203,728

 Resolution 5                             216,203,853   95.36%   10,500,212    4.63%    203,728

 Resolution 6                             216,246,519   95.38%   10,457,546    4.61%    203,728

 Resolution 7                             226,256,746   99.80%   447,319       0.20%    203,728

 Resolution 8                             155,841,995   68.79%   70,696,796    31.21%   368,502

 Resolution 9 (iii)                       155,793,930   68.78%   70,707,021    31.%     406,342

 

(i)            The "For" Proxy vote includes those giving the Chair
of the AGM discretion

(ii)           A vote "Withheld" is not a vote in law and is not
included in the proxy votes "For" or "Against" the resolution

(iii)          Special resolution

 

The full text of the resolutions can be found in the Notice of Annual General
Meeting, which is available on the Company's website at:
https://www.kanabogroup.com/investors/
(https://www.kanabogroup.com/investors/)

 

 For further information, please visit http://www.kanabogroup.com/
(http://www.kanabogroup.com/)  or contact the following:

 

Enquiries:

 

 Kanabo Group plc                                             via Peterhouse Capital

 Avihu Tamir, Chief Executive Officer                         +44 (0)20 7469 0930

 Assaf Vardimon, Chief Financial Officer

Ian Mattioli, Non-Executive Chair of the Board

 Peterhouse Capital Limited  (Financial Adviser and Broker)   +44 (0)20 7469 0930

 

 

 

About Kanabo Group Plc

 

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to
revolutionising patient care through its innovative technology platform and
disruptive product offerings. Since its inception in 2017, Kanabo has been
focused on researching, developing, and commercialising regulated medicinal
cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides
patients with video consultations, online prescriptions, and primary care
services. The Company is a leader in its field, focusing on improving patient
outcomes and providing more accessible healthcare experiences.

 

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under
the expert guidance of its technological and product expertise. Treat It
initially focuses on chronic pain management using plant-based medicine and
treatments that are currently unavailable through traditional channels.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest
quality medical treatments and more accessible healthcare experiences.

 

Visit www.kanabogroup.com (http://www.kanabogroup.com/)  for more
information.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGEASKXALKLEFA